Sonora Investment Management’s Akebia Therapeutics AKBA Stock Holding History

Sonora Investment Management’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$38K	Hold	13,100	–	–	﹤0.01%	479
2021 Q2	$50K	Hold	13,100	–	–	0.01%	395
2021 Q1	$44K	Buy	13,100 +12,100	+1,210%	+$43.6K	﹤0.01%	657
2020 Q4	$3K	Sell	1,000 -800	-44%	-$2.34K	﹤0.01%	1545
2020 Q3	$5K	Buy	+1,800	New	+$15.8K	﹤0.01%	1450
2019 Q3	–	Sell	-175	Closed	-$1K	–	1672
2019 Q2	$1K	Hold	175	–	–	﹤0.01%	1624
2019 Q1	$1K	Hold	175	–	–	﹤0.01%	1432
2018 Q4	$1K	Hold	175	–	–	﹤0.01%	1186
2018 Q3	$2K	Hold	175	–	–	﹤0.01%	1111
2018 Q2	$2K	Hold	175	–	–	﹤0.01%	1059
2018 Q1	$1.67K	Buy	+175	New	+$2.45K	﹤0.01%	1080

Other funds holding AKBA

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Sonora Investment Management's AKBA Position: Q3 2021 in Review

Sonora Investment Management held its Akebia Therapeutics (AKBA) position steady in Q3 2021 at 13,100 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #479.

Sonora Investment Management first reported a position in AKBA in Q1 2018 and has held it in 11 quarters since. The position peaked at $50K in Q2 2021. 126 funds tracked by Wall St. Rank hold AKBA as of Q3 2021.

Sonora Investment Management held 13,100 shares of Akebia Therapeutics worth $38K as of Q3 2021.
Sonora Investment Management left its Akebia Therapeutics share count unchanged in Q3 2021.
Akebia Therapeutics made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #479 holding.
Sonora Investment Management first reported a position in Akebia Therapeutics in Q1 2018 and has held it in 11 quarters since.
Sonora Investment Management's Akebia Therapeutics position peaked at $50K in Q2 2021.
126 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.